Free Trial

6,138,141 Shares in Healthpeak Properties, Inc. (NYSE:DOC) Acquired by Nuveen LLC

Healthpeak Properties logo with Finance background

Key Points

  • Nuveen LLC acquired over 6 million shares of Healthpeak Properties during Q1, representing a stake valued at approximately $124 million.
  • Analysts have set a consensus price target of $23.00 for Healthpeak Properties, with varying ratings including buy, hold, and sell.
  • Healthpeak Properties announced a monthly dividend of $0.1017 per share, yielding 7.2%, with a dividend payout ratio of 508.33%.
  • Looking to export and analyze Healthpeak Properties data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Nuveen LLC bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,138,141 shares of the real estate investment trust's stock, valued at approximately $124,113,000. Nuveen LLC owned about 0.88% of Healthpeak Properties as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of DOC. Invesco Ltd. grew its holdings in shares of Healthpeak Properties by 20.7% in the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after purchasing an additional 3,967,830 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in Healthpeak Properties by 10.6% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust's stock worth $350,021,000 after buying an additional 1,651,235 shares during the period. Centersquare Investment Management LLC increased its stake in Healthpeak Properties by 18.5% in the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock worth $268,642,000 after buying an additional 2,070,416 shares during the period. Northern Trust Corp increased its stake in Healthpeak Properties by 32.6% in the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after buying an additional 2,590,530 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in Healthpeak Properties by 0.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 10,238,001 shares of the real estate investment trust's stock worth $207,012,000 after buying an additional 84,551 shares during the period. Institutional investors own 93.57% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on DOC. Argus reaffirmed a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Scotiabank downgraded shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their price target for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wells Fargo & Company reduced their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Evercore ISI dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Wedbush dropped their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $23.00.

Read Our Latest Stock Report on DOC

Healthpeak Properties Stock Up 1.6%

Shares of NYSE:DOC traded up $0.28 during trading on Friday, reaching $17.32. The stock had a trading volume of 6,201,670 shares, compared to its average volume of 8,335,443. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26. The company has a market capitalization of $12.04 billion, a P/E ratio of 72.17, a PEG ratio of 2.21 and a beta of 1.05. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm's 50-day simple moving average is $17.64 and its 200 day simple moving average is $18.48.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. During the same period last year, the business earned $0.45 EPS. The company's revenue was down .2% compared to the same quarter last year. As a group, research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently declared a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be issued a $0.1017 dividend. This represents a dividend yield of 705.0%. The ex-dividend date is Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is currently 508.33%.

Insider Transactions at Healthpeak Properties

In other news, CEO Scott M. Brinker purchased 1,490 shares of the stock in a transaction dated Monday, August 4th. The shares were acquired at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This represents a 0.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Tommy G. Thompson bought 5,777 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was bought at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the purchase, the director directly owned 144,290 shares in the company, valued at $2,491,888.30. This represents a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 14,560 shares of company stock worth $249,898 over the last 90 days. Company insiders own 0.23% of the company's stock.

Healthpeak Properties Company Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Recommended Stories

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines